Hemoglobin Measured by "Orsense NBM-200MP" Device and Laboratory Measurement

The purpose of this study is to compare the hemoglobin results obtained with the "Orsense NBM-200MP" device and the Clinical Laboratory.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Emergency Disease Attributes Emergencies Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Foch

Suresnes, 92150, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

emergency unit patients requiring an hemoglobin determination

Exclusion criteria

none

Treatment and study plan

Primary outcomes

Hemoglobin measurement using the "Orsense NBM-200MP" device

Time frame: 4 months

Sponsors and collaborators

Lead sponsor

Hopital Foch

Other

Registry information

Official study title

Comparison of the Hemoglobin Results Obtained With the "Orsense NBM-200MP" Device and the Clinical Laboratory

Important dates

Study start: 2011
Primary completion: 2011
Study completion: 2011
First posted: Mar 23, 2011
Registry last updated: Nov 3, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed